Medication info
Gliata Min Tablet (Choline Alfoscerate)

Gliata Min Tablet (Choline Alfoscerate)

Prescription medicationTabletOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pale yellow oval film-coated tablet
Packaging
90 tablets (15 tablets/PTP x 6), 90 tablets/bottle, 10 tablets/bottle
Approval status
Active

MFDS item code 201402044 · Approved 2014.04.29 · Insurance code 694000670

Summary

Main use
Relief of secondary symptoms of organic brain syndrome (such as memory impairment) and cerebrovascular deficits
Who takes it
Adults
Adult dose
Administer 400 mg of choline alfoscerate orally 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Relief of secondary symptoms of organic brain syndrome (such as memory impairment) and cerebrovascular deficits

  • Memory impairment
  • confusion
  • impaired sense of direction
  • decreased motivation
  • decreased spontaneity
  • decreased concentration
View approved original text

This medication is used for secondary symptoms caused by cerebrovascular deficit and degenerative or atrophic organic psychoses. It particularly helps improve symptoms such as memory impairment, confusion, impaired sense of direction, and decreased concentration and spontaneity. Its effectiveness has been confirmed through domestic clinical trials.

How to take

Adult dose

Administer 400 mg of choline alfoscerate orally 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used by patients who are allergic to this medication or its components. Additionally, it is recommended that women who are pregnant or may become pregnant do not take this medication. Nausea may occur when taking this medication due to its effects on dopamine; if this symptom appears, it may be necessary to reduce the dose of the medication. Caution should be exercised as gastritis or gastrointestinal disorders may occur in the digestive system. In the central nervous system, symptoms such as drowsiness, insomnia, hostility, irritability, seizures, and excessive exertion may occur. This medication should be stored out of reach of children. Also, transferring the medication to another container may lead to accidents or reduce the quality of the medication.

Side effects

  • Regions
  • gastritis
  • stomach disorders
  • drowsiness
  • insomnia
  • aggression
  • irritability
  • seizures
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain the medication's efficacy.

Appearance and packaging

Appearance

Pale yellow oval film-coated tablet

Package unit

90 tablets (15 tablets/PTP x 6), 90 tablets/bottle, 10 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.